Description

AGPV TFA, a tetrapeptide, has the potential for prevention of schistosome parasite infection research[1].—COVID-19-immunoregulation–C17H27F3N4O7—-[1]James H. McKerrow, et al. Synthetic tetrapeptides for the prevention of schistosome parasite infection. US5284829A.—-456.41—-CC(C)[C@@H](C(O)=O)NC([C@H]1N(CCC1)C(CNC([C@@H](N)C)=O)=O)=O.O=C(O)C(F)(F)F–Infection–H2O–Parasite–Schistosome–Anti-infection–Peptides